{"count": 49, "results": [{"_id": "32744629", "pmid": 32744629, "pmcid": "PMC7399751", "title": "Association of Metformin With Pregnancy Outcomes in Women With Polycystic Ovarian Syndrome Undergoing In Vitro Fertilization", "journal": "JAMA Netw Open", "authors": ["Wu Y", "Tu M", "Huang Y", "Liu Y", "Zhang D"], "date": "2020-08-03T00:00:00Z", "doi": "10.1001/jamanetworkopen.2020.11995", "meta_date_publication": "2020 Aug 3", "meta_volume": "3", "meta_issue": "8", "meta_pages": "e2011995", "score": 50284.723, "text_hl": "...Association of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ With @<m>DISEASE_Ovarian_Hyperstimulation_Syndrome</m> @DISEASE_MESH:D016471 @@@Ovarian Hyperstimulation Syndrome@@@ (@<m>DISEASE_Ovarian_Hyperstimulation_Syndrome</m> @DISEASE_MESH:D016471 @@@OHSS@@@) Rate ", "citations": {"NLM": "Wu Y, Tu M, Huang Y, Liu Y, Zhang D. Association of Metformin With Pregnancy Outcomes in Women With Polycystic Ovarian Syndrome Undergoing In Vitro Fertilization JAMA Netw Open. 2020 Aug 3;3(8):e2011995. PMID: 32744629", "BibTeX": "@article{32744629, title={Association of Metformin With Pregnancy Outcomes in Women With Polycystic Ovarian Syndrome Undergoing In Vitro Fertilization}, author={Wu Y and Tu M and Huang Y and Liu Y and Zhang D}, journal={JAMA Netw Open}, volume={3}, number={8}, pages={e2011995}}"}}, {"_id": "37753037", "pmid": 37753037, "pmcid": "PMC10519644", "title": "Effect of Metformin (MTF) Intervention During Pregnancy in Women With Polycystic Ovarian Syndrome (PCOS): A Systematic Review", "journal": "Cureus", "authors": ["Kanda S", "Chatha U", "Odoma VA", "Pitliya A", "AlEdani EM", "Bhangu JK", "Javed K", "Manshahia PK", "Nahar S", "Hamid P"], "date": "2023-08-26T00:00:00Z", "doi": "10.7759/cureus.44166", "meta_date_publication": "2023 Aug", "meta_volume": "15", "meta_issue": "8", "meta_pages": "e44166", "score": 50272.5, "text_hl": "Eleven randomized controlled trials (RCTs) with 1,091 @SPECIES_9606 @@@women@@@ found that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MTF@@@ may lower the risk of @<m>DISEASE_Ovarian_Hyperstimulation_Syndrome</m> @DISEASE_MESH:D016471 @@@ovarian hyperstimulation syndrome@@@ (@<m>DISEASE_Ovarian_Hyperstimulation_Syndrome</m> @DISEASE_MESH:D016471 @@@OHSS@@@). ", "citations": {"NLM": "Kanda S, Chatha U, Odoma VA, Pitliya A, AlEdani EM, Bhangu JK, Javed K, Manshahia PK, Nahar S, Hamid P. Effect of Metformin (MTF) Intervention During Pregnancy in Women With Polycystic Ovarian Syndrome (PCOS): A Systematic Review Cureus. 2023 Aug;15(8):e44166. PMID: 37753037", "BibTeX": "@article{37753037, title={Effect of Metformin (MTF) Intervention During Pregnancy in Women With Polycystic Ovarian Syndrome (PCOS): A Systematic Review}, author={Kanda S and Chatha U and Odoma VA and Pitliya A and AlEdani EM and Bhangu JK and Javed K and Manshahia PK and Nahar S and Hamid P}, journal={Cureus}, volume={15}, number={8}, pages={e44166}}"}}, {"_id": "37409227", "pmid": 37409227, "pmcid": "PMC10319127", "title": "Lights and shadows on the use of metformin in pregnancy: from the preconception phase to breastfeeding and beyond", "journal": "Front Endocrinol (Lausanne)", "authors": ["Tosti G", "Barberio A", "Tartaglione L", "Rizzi A", "Di Leo M", "Viti L", "Sirico A", "De Carolis S", "Pontecorvi A", "Lanzone A", "Pitocco D"], "date": "2023-06-20T00:00:00Z", "doi": "10.3389/fendo.2023.1176623", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "1176623", "score": 50264.137, "text_hl": "@SPECIES_9606 @@@Women@@@ in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group had lower odds of @<m>DISEASE_Ovarian_Hyperstimulation_Syndrome</m> @DISEASE_MESH:D016471 @@@OHSS@@@ than @SPECIES_9606 @@@women@@@ in the control group (OR 0.43; 95% CI 0.24-0.78); in particular, @SPECIES_9606 @@@women@@@ in the subgroup with BMI > 26 had lower rates of @<m>DISEASE_Ovarian_Hyperstimulation_Syndrome</m> @DISEASE_MESH:D016471 @@@OHSS@@@ if randomized with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (OR 0.25, 95% CI 0.12-0.51). ", "citations": {"NLM": "Tosti G, Barberio A, Tartaglione L, Rizzi A, Di Leo M, Viti L, Sirico A, De Carolis S, Pontecorvi A, Lanzone A, Pitocco D. Lights and shadows on the use of metformin in pregnancy: from the preconception phase to breastfeeding and beyond Front Endocrinol (Lausanne). 2023;14():1176623. PMID: 37409227", "BibTeX": "@article{37409227, title={Lights and shadows on the use of metformin in pregnancy: from the preconception phase to breastfeeding and beyond}, author={Tosti G and Barberio A and Tartaglione L and Rizzi A and Di Leo M and Viti L and Sirico A and De Carolis S and Pontecorvi A and Lanzone A and Pitocco D}, journal={Front Endocrinol (Lausanne)}, volume={14}, pages={1176623}}"}}, {"_id": "33347618", "pmid": 33347618, "title": "Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.", "journal": "Cochrane Database Syst Rev", "authors": ["Tso LO", "Costello MF", "Albuquerque LET", "Andriolo RB", "Macedo CR"], "date": "2020-12-21T00:00:00Z", "doi": "10.1002/14651858.CD006105.pub4", "meta_date_publication": "2020 Dec 21", "meta_volume": "12", "meta_issue": "12", "meta_pages": "CD006105", "score": 50262.613, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ may reduce the incidence of @<m>DISEASE_Ovarian_Hyperstimulation_Syndrome</m> @DISEASE_MESH:D016471 @@@OHSS@@@ but may result in a higher incidence of side effects. ", "citations": {"NLM": "Tso LO, Costello MF, Albuquerque LET, Andriolo RB, Macedo CR. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2020 Dec 21;12(12):CD006105. PMID: 33347618", "BibTeX": "@article{33347618, title={Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.}, author={Tso LO and Costello MF and Albuquerque LET and Andriolo RB and Macedo CR}, journal={Cochrane Database Syst Rev}, volume={12}, number={12}, pages={CD006105}}"}}, {"_id": "39485003", "pmid": 39485003, "title": "Is metformin safe in pregnancy: a focus on offspring outcomes.", "journal": "Expert Opin Drug Saf", "authors": ["Malek R", "Davis SN"], "date": "2024-11-04T00:00:00Z", "doi": "10.1080/14740338.2024.2424410", "meta_date_publication": "2024 Nov 4", "meta_volume": "", "meta_issue": "", "meta_pages": "1-4", "score": 50261.273, "text_hl": "Is @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ safe in pregnancy: a focus on offspring outcomes.", "citations": {"NLM": "Malek R, Davis SN. Is metformin safe in pregnancy: a focus on offspring outcomes. Expert Opin Drug Saf. 2024 Nov 4;():1-4. PMID: 39485003", "BibTeX": "@article{39485003, title={Is metformin safe in pregnancy: a focus on offspring outcomes.}, author={Malek R and Davis SN}, journal={Expert Opin Drug Saf}, pages={1-4}}"}}, {"_id": "39702393", "pmid": 39702393, "title": "Comparative efficacy and safety of metformin, anti-obesity agents, and myoinositol in improving IVF/ICSI outcomes and reducing ovarian hyperstimulation syndrome in women with polycystic ovary syndrome: a systematic review and network meta-analysis.", "journal": "J Ovarian Res", "authors": ["Lin L", "Chen G", "Qiao X", "Chen Y", "Deng H", "Xu L"], "date": "2024-12-19T00:00:00Z", "doi": "10.1186/s13048-024-01576-0", "meta_date_publication": "2024 Dec 19", "meta_volume": "17", "meta_issue": "1", "meta_pages": "249", "score": 50259.62, "text_hl": "Network meta-analysis confirmed no significant differences in pregnancy outcomes for these agents compared to controls, though both @CHEMICAL_Inositol @CHEMICAL_MESH:D007294 @@@myoinositol@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ reduced @<m>DISEASE_Ovarian_Hyperstimulation_Syndrome</m> @DISEASE_MESH:D016471 @@@OHSS@@@ risk. ", "citations": {"NLM": "Lin L, Chen G, Qiao X, Chen Y, Deng H, Xu L. Comparative efficacy and safety of metformin, anti-obesity agents, and myoinositol in improving IVF/ICSI outcomes and reducing ovarian hyperstimulation syndrome in women with polycystic ovary syndrome: a systematic review and network meta-analysis. J Ovarian Res. 2024 Dec 19;17(1):249. PMID: 39702393", "BibTeX": "@article{39702393, title={Comparative efficacy and safety of metformin, anti-obesity agents, and myoinositol in improving IVF/ICSI outcomes and reducing ovarian hyperstimulation syndrome in women with polycystic ovary syndrome: a systematic review and network meta-analysis.}, author={Lin L and Chen G and Qiao X and Chen Y and Deng H and Xu L}, journal={J Ovarian Res}, volume={17}, number={1}, pages={249}}"}}, {"_id": "37528417", "pmid": 37528417, "pmcid": "PMC10391774", "title": "Women with PCOS who undergo IVF: a comprehensive review of therapeutic strategies for successful outcomes", "journal": "Reprod Biol Endocrinol", "authors": ["Kotlyar AM", "Seifer DB"], "date": "2023-08-01T00:00:00Z", "doi": "10.1186/s12958-023-01120-7", "meta_date_publication": "2023 Aug 1", "meta_volume": "21", "meta_issue": "1", "meta_pages": "70", "score": 50259.234, "text_hl": "Concerning stimulation protocols, antagonist cycles with the judicious use of @GENE_GNRH1 @GENE_2796 @@@GnRH@@@ agonist trigger, pre-treatment with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Vitamin_D @CHEMICAL_MESH:D014807 @@@vitamin D@@@ repletion may help mitigate the accompanied risk of @<m>DISEASE_Ovarian_Hyperstimulation_Syndrome</m> @DISEASE_MESH:D016471 @@@ovarian hyperstimulation syndrome@@@ (@<m>DISEASE_Ovarian_Hyperstimulation_Syndrome</m> @DISEASE_MESH:D016471 @@@OHSS@@@). ", "citations": {"NLM": "Kotlyar AM, Seifer DB. Women with PCOS who undergo IVF: a comprehensive review of therapeutic strategies for successful outcomes Reprod Biol Endocrinol. 2023 Aug 1;21(1):70. PMID: 37528417", "BibTeX": "@article{37528417, title={Women with PCOS who undergo IVF: a comprehensive review of therapeutic strategies for successful outcomes}, author={Kotlyar AM and Seifer DB}, journal={Reprod Biol Endocrinol}, volume={21}, number={1}, pages={70}}"}}, {"_id": "33709434", "pmid": 33709434, "title": "Metformin and health outcomes: An umbrella review of systematic reviews with meta-analyses.", "journal": "Eur J Clin Invest", "authors": ["Li X", "Celotto S", "Pizzol D", "Gasevic D", "Ji MM", "Barnini T", "Solmi M", "Stubbs B", "Smith L", "López Sánchez GF", "Pesolillo G", "Yu Z", "Tzoulaki I", "Theodoratou E", "Ioannidis JPA", "Veronese N", "Demurtas J"], "date": "2021-07-01T00:00:00Z", "doi": "10.1111/eci.13536", "meta_date_publication": "2021 Jul", "meta_volume": "51", "meta_issue": "7", "meta_pages": "e13536", "score": 50255.246, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and health outcomes: An umbrella review of systematic reviews with meta-analyses.", "citations": {"NLM": "Li X, Celotto S, Pizzol D, Gasevic D, Ji MM, Barnini T, Solmi M, Stubbs B, Smith L, López Sánchez GF, Pesolillo G, Yu Z, Tzoulaki I, Theodoratou E, Ioannidis JPA, Veronese N, Demurtas J. Metformin and health outcomes: An umbrella review of systematic reviews with meta-analyses. Eur J Clin Invest. 2021 Jul;51(7):e13536. PMID: 33709434", "BibTeX": "@article{33709434, title={Metformin and health outcomes: An umbrella review of systematic reviews with meta-analyses.}, author={Li X and Celotto S and Pizzol D and Gasevic D and Ji MM and Barnini T and Solmi M and Stubbs B and Smith L and López Sánchez GF and Pesolillo G and Yu Z and Tzoulaki I and Theodoratou E and Ioannidis JPA and Veronese N and Demurtas J}, journal={Eur J Clin Invest}, volume={51}, number={7}, pages={e13536}}"}}, {"_id": "34590929", "pmid": 34590929, "title": "Myoinositol versus metformin pretreatment in GnRH-antagonist cycle for women with PCOS undergoing IVF: a double-blinded randomized controlled study.", "journal": "Gynecol Endocrinol", "authors": ["Rajasekaran K", "Malhotra N", "Mahey R", "Khadgawat R", "Kalaivani M"], "date": "2022-02-01T00:00:00Z", "doi": "10.1080/09513590.2021.1981282", "meta_date_publication": "2022 Feb", "meta_volume": "38", "meta_issue": "2", "meta_pages": "140-147", "score": 50255.117, "text_hl": "OBJECTIVE: To study the effects of @CHEMICAL_Inositol @CHEMICAL_MESH:D007294 @@@myoinositol@@@ (@CHEMICAL_Inositol @CHEMICAL_MESH:D007294 @@@Myo@@@) in comparison to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@GENE_SLTM @GENE_79811 @@@Met@@@), in reducing the risk of @<m>DISEASE_Ovarian_Hyperstimulation_Syndrome</m> @DISEASE_MESH:D016471 @@@OHSS@@@ and improving ART outcome in @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ @SPECIES_9606 @@@women@@@ undergoing @DISEASE_Paroxysmal_ventricular_fibrillation @DISEASE_MESH:C537182 @@@IVF@@@. ", "citations": {"NLM": "Rajasekaran K, Malhotra N, Mahey R, Khadgawat R, Kalaivani M. Myoinositol versus metformin pretreatment in GnRH-antagonist cycle for women with PCOS undergoing IVF: a double-blinded randomized controlled study. Gynecol Endocrinol. 2022 Feb;38(2):140-147. PMID: 34590929", "BibTeX": "@article{34590929, title={Myoinositol versus metformin pretreatment in GnRH-antagonist cycle for women with PCOS undergoing IVF: a double-blinded randomized controlled study.}, author={Rajasekaran K and Malhotra N and Mahey R and Khadgawat R and Kalaivani M}, journal={Gynecol Endocrinol}, volume={38}, number={2}, pages={140-147}}"}}, {"_id": "36285403", "pmid": 36285403, "title": "Effectiveness of inositol, metformin and their combination in women with PCOS undergoing assisted reproduction: systematic review and meta-analysis.", "journal": "Gynecol Endocrinol", "authors": ["Unanyan A", "Pivazyan L", "Krylova E", "Eskin A", "Zakaryan A", "Sarkisova A", "Ishchenko A"], "date": "2022-10-26T00:00:00Z", "doi": "10.1080/09513590.2022.2136160", "meta_date_publication": "2022 Oct 26", "meta_volume": "", "meta_issue": "", "meta_pages": "1-12", "score": 50246.184, "text_hl": "@<m>DISEASE_Ovarian_Hyperstimulation_Syndrome</m> @DISEASE_MESH:D016471 @@@OHSS@@@ was less in @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (RR = 0.34, 95% CI: 0.17 to 0.69, p = 0.003). ", "citations": {"NLM": "Unanyan A, Pivazyan L, Krylova E, Eskin A, Zakaryan A, Sarkisova A, Ishchenko A. Effectiveness of inositol, metformin and their combination in women with PCOS undergoing assisted reproduction: systematic review and meta-analysis. Gynecol Endocrinol. 2022 Oct 26;():1-12. PMID: 36285403", "BibTeX": "@article{36285403, title={Effectiveness of inositol, metformin and their combination in women with PCOS undergoing assisted reproduction: systematic review and meta-analysis.}, author={Unanyan A and Pivazyan L and Krylova E and Eskin A and Zakaryan A and Sarkisova A and Ishchenko A}, journal={Gynecol Endocrinol}, pages={1-12}}"}}]}